精准医学的前景在硬化皮质硬化症中的精准医学
Kazuhiro Komura1,2, Koichi Yanaba3, Jean-David Bouaziz4
1Department of Dermatology, Kanazawa Red Cross Hospital, Japanese Red Cross Society, Kanazawa, Japan.
Frontiers in immunology
|February 2, 2024
概括
系统性硬化症 (SSc) 研究面临的挑战是由于疾病的稀有性和异质性. 个性化医疗,以体外药物反应测试为指导,对患者的纤维细胞进行测试,为SSc.提供了优化治疗策略的途径.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 系统性硬化症 (SSc) 是一种罕见的,异质的自身免疫性疾病.
- 鉴定环境和遗传风险因素是具有挑战性的,因为患者人群很小.
- 疾病的复杂性需要个性化或精准医学方法.
研究的目的:
- 为改善SSc.治疗策略奠定基础.
- 提高针对性治疗的临床试验设计.
- 探索体外药物反应测试以进行个性化治疗选择.
主要方法:
- 基于受影响区域和疾病标志物 (例如,自身抗体) 的SSc的分类.
- 临床前体外药物反应测试使用患者衍生纤维细胞.
- 在培养中分析纤维细胞表型.
主要成果:
- 结核病皮肤纤维细胞在体外表现出一种持续的高生产性表型.
- 在体外药物反应测试可以识别精确的疾病标志物.
- 这种方法有助于为个别患者进行治疗选择.
结论:
- 个性化医疗对于管理SSc异质性至关重要.
- 试验室药物反应测定提供了指导SSc治疗的精确方法.
- 基于疾病标志物的累积方法优化了患者的护理和生活质量.
相关概念视频
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K